Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 ,inter alia, to consider and approve 1. To consider and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has informed BSE that its Board of Directors will meet on Saturday, 12 April 2025. The key agenda is to approve convening an Extraordinary General Meeting (EGM) to seek shareholder approval for confirming the appointment of Mr. Lakshman Samala as a Non-Executive Independent Director. The Board will also appoint a scrutinizer to oversee the voting process at the upcoming EGM. The filing is made under SEBI Listing Regulations (Reg. 29) as a standard prior intimation. The letter is signed by Whole-time Director Venkateshwarlu Pulluru.
This is a routine governance filing and is unlikely to have a material impact on the stock price. Shareholders will get a chance to vote on the new Independent Director's appointment at the EGM, which is a standard corporate governance step.